Semaglutide and GLP-1 Marketing for Med Spas: The 2026 Playbook

Should a med spa run a GLP-1 weight loss program?

A med spa should run a GLP-1 program if it can staff the medical oversight, source the drug through a defensible channel, and commit to a monthly follow-up cadence for at least a year. GLP-1 is the only line on a med spa menu that produces contracted recurring revenue from a first visit, and it brings in a patient demographic that neurotoxin and filler marketing rarely reach on their own.

The case against running one is operational rather than commercial. A GLP-1 program adds a prescribing relationship, dose titration, side-effect management, refill logistics, and a monthly check-in that competes for the same provider hours the injectable schedule needs. A med spa that adds GLP-1 without adding capacity generally discovers within two quarters that the program consumed provider time worth more than the program earned.

The commercial case is straightforward. A neurotoxin client returns every twelve to fourteen weeks and generates four visits a year. A GLP-1 member is billed every month and touches the clinic twelve times. That difference in contact frequency, not the drug margin, is what makes the line worth marketing. Twelve touchpoints per year is twelve opportunities to book a facial, a laser series, or a package that the client would never have shopped for on their own.

• ·Add the program only with dedicated provider hours, not with borrowed injectable hours
• ·Price it monthly, contract it in three-month blocks, and market it as enrollment rather than as a single appointment
• ·Budget for a monthly follow-up that is a real clinical touch, because it is also the cross-sell moment
• ·Decide the sourcing and claims position with counsel before a single ad is written

What does a GLP-1 patient earn a med spa per month?

A med spa GLP-1 program typically bills $199 to $599 per member-month depending on whether the clinic supplies the medication or supervises a patient who obtains it elsewhere. Gross margin per member-month runs roughly $90 to $260 once medication cost, provider time, supplies, and payment processing are subtracted. That margin sits inside the $120 to $280 member LTV per month band ClinicAds uses across med spa membership lines, which is why GLP-1 slots cleanly into a membership-style program rather than into the per-appointment model.

The table below sets out the three program structures ClinicAds sees in the field. The figures are illustrative planning ranges drawn from med spa account reviews, not guarantees, and drug acquisition cost in particular moves with sourcing and manufacturer programs.

• ·Enrollment fee at intake: $150 to $350, usually covering labs, the initial medical visit, and body composition baseline
• ·Three-month minimum commitment raises average program length by roughly 1.5 to 2.5 months against month-to-month billing
• ·Hybrid membership carries the lowest monthly margin and the highest twelve-month value, because the aesthetic credit forces a second reason to visit

What does it cost to acquire a GLP-1 patient?

A med spa pays $22 to $48 per GLP-1 lead and $45 to $80 per booked consultation in 2026, which puts the line at the upper end of the $28 to $80 med spa cost-per-booked-appointment band. Enrollment is the number that actually matters, and 45 to 65 percent of consultations enroll, which puts cost per enrolled member at roughly $75 to $175. These are agency averages across active med spa accounts, not guarantees.

Compare that against the margin table above and the payback picture is clear. At a $140 cost per enrolled member and a $180 gross margin per member-month, the acquisition cost is repaid inside the first billing cycle and every subsequent month is program margin. That is the reason a med spa can run GLP-1 at a cost per booked appointment that would be unacceptable on a neurotoxin campaign. Neurotoxin at $45 per booked appointment buys one visit worth $350 to $650. GLP-1 at $140 per enrolled member buys a subscription.

The variable that ruins this math is enrollment rate rather than lead cost. A med spa converting 25 percent of GLP-1 consultations pays roughly $260 per enrolled member for the same media, which pushes payback past month two and makes the program fragile to early churn. In ClinicAds account reviews, the difference between a 30 percent and a 60 percent enrollment rate is almost always the consultation itself: price disclosed up front in the ad and on the page, labs and screening explained before the visit, and a provider who presents one recommended plan rather than a menu.

• ·Cost per GLP-1 lead: $22 to $48
• ·Cost per booked GLP-1 consultation: $45 to $80
• ·Consultation to enrollment: 45 to 65 percent in a well-run program, 25 to 35 percent where price is withheld until the visit
• ·Cost per enrolled member: $75 to $175, repaid inside the first or second billing cycle

Which channels fill a med spa GLP-1 program?

Meta and Instagram fill most of a med spa GLP-1 program because the demand is latent rather than searched, and paid social is the only channel that reaches a person who has been considering weight treatment for months without typing anything into Google. Google Search captures the smaller in-market segment at a higher cost and a higher enrollment rate. The existing client database is the cheapest source of enrollments in the entire mix and the one most med spas run last.

The table below is the allocation ClinicAds starts from on a GLP-1 launch at a $3,000 to $8,000 monthly med spa budget. Database reactivation is listed first by efficiency rather than by spend, because it costs almost nothing and converts at multiples of paid. Figures are agency averages, not guarantees.

How do GLP-1 patients become aesthetic revenue?

The aesthetic cross-sell is the entire reason a med spa should be in GLP-1 and a national telehealth brand should not be able to compete. A patient losing 15 to 20 percent of body weight develops a predictable set of aesthetic concerns, arrives at the clinic twelve times over a year, and is already paying the clinic monthly. A telehealth app can prescribe. It cannot put a body-contouring consultation in front of the same patient in month five.

The cross-sell that converts is scheduled rather than offered. A med spa that mentions treatments when the patient brings up facial volume loss captures a fraction of the opportunity. A med spa that books a standing skin and body assessment at month four, before the patient has decided anything, captures most of it. The month-four visit is a clinical checkpoint that happens to be the highest-intent aesthetic consultation the clinic will run all year.

The table below runs 100 enrolled GLP-1 members through twelve months at two operating levels, holding cost per enrolled member constant at $140. The only differences are program retention and whether an aesthetic assessment is scheduled into the protocol. Cohort revenue over twelve months is a different measurement than the in-period 4 to 8 times return on ad spend ClinicAds reports on med spa media, and the two should not be compared directly. Illustrative model, not guaranteed results.

• ·Month 4: scheduled skin and body assessment, positioned as a clinical checkpoint rather than a sales visit
• ·Months 5 to 8: skin quality and facial volume are the concerns patients raise first
• ·Months 7 to 12: body contouring and skin tightening, once weight has largely stabilized
• ·Post-program: convert the GLP-1 member into an aesthetic membership rather than letting the billing relationship end

Can med spas advertise semaglutide on Meta and Google?

Med spas can advertise a medical weight management program on Meta and Google, with real constraints on how it is described. Meta prohibits ad copy that implies knowledge of a person's weight or health status, restricts before-and-after body imagery, and requires weight loss ads to be limited to adults 18 and over. Google restricts prescription drug promotion to certified advertisers and treats brand drug names as regulated pharmaceutical content rather than as ordinary keywords.

The practical consequence for a med spa is that the program, not the molecule, is the advertised object. Ads for a physician-supervised weight management program with monthly follow-up clear review consistently. Ads naming a brand drug, showing a scale, promising a pound count, or implying the viewer is overweight get disapproved and put the ad account at risk. A med spa can still rank organically and answer directly on its own site for brand-name queries, where the constraint is medical accuracy rather than ad policy.

ClinicAds treats the site page as the place specificity lives and the ad as the place it does not. That split is also why the compliant version usually performs better. An ad selling supervision, labs, monthly provider contact, and a clear monthly price attracts the patient who intends to complete a program. An ad selling a number on a scale attracts the patient who cancels in month two. The full platform-by-platform policy breakdown, including appeal and recovery after a flag, is in the ClinicAds telehealth post on advertising GLP-1 without getting flagged.

• ·Advertise the program and the supervision, not the drug name or a pound count
• ·No before-and-after body imagery, no scales, no copy that addresses the viewer's body
• ·Set the 18-and-over audience restriction on weight-related campaigns
• ·Put price, screening requirements, and what is included on the landing page, where policy is lighter and enrollment rate is decided

What changed for compounded semaglutide supply?

The compounded-semaglutide picture changed in 2025 and has not reverted. The FDA declared the semaglutide shortage resolved in February 2025 and the tirzepatide shortage resolved in December 2024, which removed the shortage-based basis for compounding pharmacies to produce copies of the branded drugs. Enforcement dates for 503A and 503B facilities followed in the spring of 2025. Any med spa building a 2026 marketing program around a compounded copy is operating in a materially different legal environment than the one that existed in 2024.

This is a sourcing and legal question rather than a marketing question, and ClinicAds does not give legal advice. What it does change about marketing is concrete: claims, pricing, and program descriptions written when compounded product was inexpensive and freely available do not survive a switch to branded supply. A med spa that quietly repriced from $299 to $549 while running eighteen-month-old ad copy will see enrollment rate collapse at the consultation and will blame the ads.

The practical sequence is to settle sourcing first, rebuild the price and program description second, and turn media on third. A med spa should have its pharmacy relationship, its prescribing protocol, and its advertising claims reviewed by healthcare counsel before spending on acquisition, because the cost of rebuilding a program mid-campaign is far higher than the cost of the review.

How do med spas keep GLP-1 patients past month three?

Month three is where med spa GLP-1 programs break. Discontinuation is front-loaded across the category, and the reasons cluster into four causes: side effects during titration, cost against a plateau in visible results, insurance or supply disruption, and the patient deciding they can continue on their own. A med spa that treats all four as one problem and responds with a discount keeps almost none of them.

The interventions are specific and they are operational rather than promotional. Side effects are handled by a proactive call in week two of each dose increase rather than by waiting for the patient to report a problem. The cost objection is handled by measuring something other than the scale, because a patient shown waist circumference, body composition, and photos in month three has evidence of progress the scale may not be showing that week. Supply is handled by refilling on a fixed calendar rather than on patient request. The self-management exit is handled by making the monthly visit clinically worth attending.

Retention is worth more than acquisition on this line by a wide margin. Extending average program length from 5.5 to 9 months, as in the cohort table above, adds roughly $140,000 in program revenue per 100 members without buying a single additional lead. A med spa spending on GLP-1 acquisition before it has a month-three protocol is paying to fill a program it will lose.

• ·Week 2 of every dose increase: proactive provider call, not a portal message
• ·Month 3: measured progress review with circumference, body composition, and photos, not the scale alone
• ·Fixed refill calendar, with the next month dispensed or shipped before the patient runs out
• ·Month 4: scheduled skin and body assessment, which is both a clinical checkpoint and the cross-sell moment
• ·Dormancy trigger at 45 days without a billed month, worked by phone rather than by automated email

What GLP-1 marketing mistakes cost med spas the most?

The most expensive GLP-1 marketing mistake a med spa makes is competing with national telehealth brands on price. A national brand buying at scale can advertise a monthly figure a single clinic cannot match, and a med spa that anchors its marketing on price is competing on the one dimension where it is structurally disadvantaged. The clinic's advantages are in-person medical oversight, labs and body composition measured rather than self-reported, and an aesthetic menu the app does not have.

The second mistake is hiding price until the consultation. It reliably produces cheap leads, a full consultation calendar, and an enrollment rate near 25 percent, which is a worse outcome at a higher cost per enrolled member than a smaller number of pre-qualified consultations. The third is running GLP-1 creative that looks like weight-loss direct response, which draws ad-policy scrutiny and attracts the price-shopping patient who churns first.

The fourth mistake is measuring the program on cost per booked appointment. GLP-1 is a subscription, and a med spa reporting it on the same dashboard row as neurotoxin will misread a healthy program as an expensive one. ClinicAds reports GLP-1 on cost per enrolled member, average program length in months, and twelve-month revenue per acquisition dollar including aesthetic cross-sell. Those three numbers describe the line correctly. Cost per booked appointment does not.

• ·Do not lead with price against national telehealth brands; lead with in-person oversight and the aesthetic menu
• ·Publish the monthly price on the landing page; enrollment rate roughly doubles against withholding it
• ·Do not launch acquisition before the month-three retention protocol exists
• ·Report on cost per enrolled member and program length, not cost per booked appointment